Effects of donepezil 23 mg on Severe Impairment Battery domains in patients with moderate to severe Alzheimer's disease: evaluating the impact of baseline severity Introduction The US Food and Drug Administration approved a 23 mg daily dose of donepezil for treatment of moderate to severe Alzheimer's disease based on outcomes from a large trial ... (more)
http://www.citeulike.org/user/paldaily/article/12270622
http://www.citeulike.org/user/paldaily/article/12270622
No comments:
Post a Comment